XML 32 R26.htm IDEA: XBRL DOCUMENT v3.25.3
Net Income Per Share (Tables)
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Schedule of computation of basic and diluted net income per share

The following table shows the computation of basic and diluted net income per share for the three and nine months ended September 30, 2025 and 2024:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

(In thousands except per share data)

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net income, basic

 

$

89,908

 

 

$

1,213

 

 

$

107,012

 

 

$

3,060

 

Add: interest expense on 2025 Notes, net of tax effect

 

 

566

 

 

 

 

 

 

2,820

 

 

 

 

Add: interest expense on 2028 Notes, net of tax effect

 

 

1,416

 

 

 

 

 

 

4,238

 

 

 

 

Net income, diluted

 

$

91,890

 

 

$

1,213

 

 

$

114,070

 

 

$

3,060

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average shares used to compute basic
   net income per share

 

 

69,058

 

 

 

62,569

 

 

 

64,901

 

 

 

62,759

 

Dilutive effect of 2025 Notes

 

 

5,467

 

 

 

 

 

 

9,235

 

 

 

 

Dilutive effect of 2028 Notes

 

 

9,955

 

 

 

 

 

 

9,955

 

 

 

 

Dilutive effect of options and awards granted under equity
   incentive plan and employee stock purchase plan

 

 

462

 

 

 

372

 

 

 

464

 

 

 

261

 

Dilutive effect of outstanding warrant

 

 

22

 

 

 

10

 

 

 

21

 

 

 

 

Weighted-average shares used to compute diluted
   net income per share

 

 

84,964

 

 

 

62,951

 

 

 

84,576

 

 

 

63,020

 

Net income per share

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

1.30

 

 

$

0.02

 

 

$

1.65

 

 

$

0.05

 

Diluted

 

$

1.08

 

 

$

0.02

 

 

$

1.35

 

 

$

0.05

 

Schedule of anti-dilutive securities

The following common stock equivalents were not included in the computation of diluted net income per share because their effect was anti-dilutive for the periods presented:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

(In thousands)

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Outstanding options and awards granted under equity incentive
   plan and employee stock purchase plan

 

 

1,520

 

 

 

1,111

 

 

 

1,482

 

 

 

1,434

 

Outstanding stock warrant

 

 

 

 

 

 

 

 

 

 

 

591

 

Outstanding 2025 Notes

 

 

 

 

 

11,150

 

 

 

 

 

 

11,150

 

Outstanding 2028 Notes

 

 

 

 

 

9,955

 

 

 

 

 

 

9,955

 

Total

 

 

1,520

 

 

 

22,216

 

 

 

1,482

 

 

 

23,130